- Global Pharma News & Resources

Gumboro Disease Market Size 2019, Global Industry Analysis By Share, Growth, Technology Trends, Report Study Overview, Competitive Landscape, Key Players, Insight, And Regional Forecast To 2026

Gumboro disease also called infectious bursal disease (IBD), is a viral disease that is caused by infectious bursal disease virus (IBDV), which primarily targets the immune system of chickens. This disease is prevalent among turkeys and ducks, who are not induced with immunosuppression. Gumboro disease is a highly contagious disease that occurs in chickens over 3 weeks of age. The disease is associated with various symptoms such as staining of feathers around the vent with feces and urates, ruffled feathers, anorexia dehydration in the pectoral, thigh, and abdominal muscles, coupled with impaired kidneys by chronic urate diathesis. Subclinical infection results in deficiency in immunological response to infectious Bronchitis, Newcastle disease, Marek’s disease, as well as increase susceptibility to gangrenous dermatitis and Inclusion Body Hepatitis. Supplement of multivitamin and facilitating access to water might help in curing the disease, as no medical treatment for this disease has been developed.

Request Sample Copy of the Business Report:

High transmission rate of Gumboro disease and rising need to prevent it, are the important factors that are expected to drive growth of the gumboro disease market

Increasing prevalence rate of Gumboro disease is affecting the poultry industry drastically. This is a contiguous disease and it is easy to transmit, as infected chickens sheds the infection in their feces resulting in to the loss of poultry business. Requirement of proper treatment for Gumboro disease to reduce loss is expected to drive growth of the Gumboro disease market. For instance, according to the data published by Science Alert in 2013, economic loss due to Gumboro disease in Nigeria for 2009, 2010, and 2011 accounted for over 3 billion Nigerian currency. Moreover, according to the data published by Centre d’etudes et de Recherché, Belgium in 2000, the mortality rate due to Gumboro disease in the U.S. was 5%, whereas in Japan and Europe the rate is high 50% to 60% in laying hens and 25% to 30% in broilers.

However, increasing research and developments with new vaccines in the pipeline for the prevention from Gumboro disease are expected to propel the Gumboro disease market growth over the forecast period. For instance, the Transmune IBD vaccines available by CEVA manufacturers has proven effective for Gumboro disease.

Tailored Information as per niche requirement:

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @

New vaccine development and their effective results are accounting for the larger share of vaccine segment in Gumboro disease market

The global Gumboro disease market is segmented by species type, by vaccines type, and by region

On the basis of species type, the Gumboro Disease Market is segmented into:

  • Broilers
  • Layers

On the basis of vaccines type, the Gumboro disease market is segmented into:

  • Conventional Vaccines
  • Antibody/ Antigen Complex Vaccines
  • Vectored Vaccines

High rate of chicken consumers in North America is the driving factor for gumboro disease market in this region

Regional segmentation of Gumboro Disease Market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold the major share in the Gumboro disease market due to the high prevalence of gumboro disease and increasing investment in the research and development. The U.S. is the largest broiler chicken industry in the world. For instance, according to the National Chicken Council, in 2015, there was around 9 billion production of broiler chicken in the U.S. The chicken consumers are more in this region than any other regions in world, so the chances of poultry industry getting affected by Gumboro disease and loss caused by it is more in America, which is expected to drive growth of the Gumboro disease market in North America.

To understand Research Methodology, please click

Rapid development in the field of vaccinology and novel biotechnology tools are helping the industry players to progress in the gumboro disease market

Key industry players operating the Gumboro Disease Market include Ceva, ROMVAC Company SA, PTSanbe Farma, Jiangyin Caina Technology co. limited, Cios Co., Salfarm Danmark A/s., Vetbiochem, and others.

Growing research and development in the vaccine technology field and increase in rate of gumboro disease is encouraging the vaccine manufacturers to invest in gumboro disease market. Rapid development in the area of immunology, animal science, and biotechnology is giving rise to new biotechnology tools for helping the industry players to sustain in the gumboro disease market.

Table of Content

Global Gumboro Disease Market Research Report
Section 1: Global Gumboro Disease Industry Overview
Section 2: Global Economic Impact on Gumboro Disease Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Gumboro Disease Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Gumboro Disease Market Forecast

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 08-Mar-2021